SCHEMBL4479251

SCHEMBL4479251

CC(O)C#CC(C)(O)C(C)(C)C

nearest known ligand 0.31

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 1/20 0.31
ATM Q13315 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4467066 0.81 ALDH1A1 (0.32)
SCHEMBL4575258 0.80
SCHEMBL4575265 0.80
SCHEMBL179451 0.77
SCHEMBL12056984 0.77
SCHEMBL22618865 0.72
SCHEMBL1704294 0.72
SCHEMBL4478986 0.70
Hydrochloric Acid SCHEMBL5158353 0.70
SCHEMBL11422398 0.69 ALDH1A1 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1742929-B1 Trisubstituted furans suitable for the preparation of fragrance compositions GIVAUDAN SA (CH) 2012-06-20 EP disclosed
US-7632790-B2 2,2-Disubstituted-5-methyl-2,5-dihydro- and 2,2-disubstituted 5-methyl-tetrahydrofurans; 2-tert-butyl-5-methyl-2-propyl-2,5-dihydrofuran or tetrahydrofuran;black currant odorants free of any sulfur by-products; fruity; impart naturalness andfreshness; cosmetics; toiletries; laundering GIVAUDAN S.A. (CH) 2009-12-15 US disclosed
US-20080039360-A1 Trisubstituted Furans Suitable For The Preparation Of Fragrance Compositions GIVAUDAN S.A. (CH) 2008-02-14 US disclosed
EP-1742929-A1 TRISUBSTITUTED FURANS SUITABLE FOR THE PREPARATION OF FRAGRANCE COMPOSITIONS Givaudan SA (CH) 2007-01-17 EP disclosed
WO-2005087756-A1 TRISUBSTITUTED FURANS SUITABLE FOR THE PREPARATION OF FRAGRANCE COMPOSITIONS GIVAUDAN SA (CH) 2005-09-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080039360-A1 Trisubstituted Furans Suitable For The Preparation Of Fragrance Compositions TAS2R5, TAS2R1, DHPS KMT2A 813/4885ATM 3596/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.